Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer

Leggi l'articolo originale

Cancer is a strong risk factor for venous thromboembolism. For decades, standard treatment for all patients with venous thromboembolism consisted of heparin followed by warfarin. The rate of recurrent venous thromboembolism among patients receiving warfarin was consistently higher in those with…

Lascia un commento